Novel radiolabeled ligand, Para-chloro-2-[<sup>18</sup>F]fluoroethyletomidate (CETO) compared to [<sup>11</sup>C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)Emily Goodchild, Morris J. Brown, Anju Sadhev et al.|Endocrine Abstracts|2022Cited by 1
Somatic Mutations of GNA11 and GNAQ in CTNNB1-Mutant Aldosterone-Producing Adenomas Increases Aldosterone and Aldosterone Synthase (CYP11B2)Elena Azizan, Morris J. Brown, Junhua Zhou et al.|Journal of the Endocrine Society|2021Cited by 0
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.Giulia Argentesi, Morris J. Brown, Elena Azizan et al.|Endocrine Abstracts|2021Cited by 0
Method of venesection and location of peripheral sample alter adrenal venous sampling results and interpretation in primary aldosteronismVishnou Mourougavelou, Sam O’Toole, Xilin Wu et al.|Endocrine Abstracts|2021Cited by 0
Complete clinical cure of primary aldosteronism (PA) is predictable and sustained for at least two yearsEmily Goodchild, Morris J. Brown, Xi‐Lin Wu et al.|Endocrine Abstracts|2022Cited by 0